Hypodense Liver Lesion on CT: What Does It Mean?

A hypodense liver lesion on CT is an area that looks darker than the surrounding liver on the scan. 'Lesion' simply means an area that looks different; it does not mean cancer. Many of these spots are found by chance and turn out to be benign, such as fluid-filled cysts or haemangiomas.

The American Academy of Family Physicians (AAFP) notes that liver 'incidentalomas' appear on up to 15% of CT studies and that benign liver findings are common. This guide helps you understand the wording on your report and prepare questions. It cannot tell you what your own spot is.

Most people with an incidental liver spot have no symptoms from it. Do not wait for a routine follow-up appointment if new symptoms appear.

The NHS advises an urgent GP appointment or NHS 111 (or your local urgent service) if your skin or the whites of your eyes turn yellow. Itchy skin, darker urine and paler stools can come with this.

• Yellow skin or yellow whites of the eyes (jaundice): get urgent medical advice the same day.
• Jaundice with sudden fever, confusion, strong tummy pain or vomiting blood: Healthdirect advises calling emergency services.
• Pain in the belly that lasts more than a few days: Cleveland Clinic advises talking to a healthcare provider.
• A new lump under the right ribs, or pain in the right side of the belly or right shoulder: book a prompt review.

Radiologists sometimes write that a hypodense spot is 'too small to characterise', often shortened to TSTC. It means the spot is so small that the scan cannot show enough detail to say confidently what it is. The phrase describes a limit of the image, not a worrying feature of the spot.

Very small spots are often left alone in people at low risk. The AAFP, summarising American College of Radiology (ACR) advice from 2014, says the ACR recommends no further work-up in low-risk people with liver spots smaller than 5 mm, or larger spots with very low density or clearly benign features. Your team may follow newer local guidance, so ask what applies to you.

The same summary lists features that raise more questions: solid spots 5 mm or larger, ill-defined edges, a mixed appearance, contrast uptake, or growth over time. Your report may mention some of these words.

A review in Hepatology Communications, a journal of the American Association for the Study of Liver Diseases, describes benign liver lesions as among the most common findings on liver imaging. The usual benign causes include:

• Simple liver cysts: fluid-filled sacs. The AAFP says simple cysts may not need further tests or monitoring, and are not treated when they cause no symptoms.
• Haemangiomas: clusters of abnormal blood vessels. Cleveland Clinic calls them the most common benign liver lesion, found in about 5% of people, and says they do not turn into cancer. Most need no treatment.
• Focal nodular hyperplasia (FNH): a benign area of liver tissue linked to altered blood flow. The review names it the second most common solid benign lesion.
• Liver adenomas: benign growths that the review says usually need contrast MRI to assess, because they are managed differently from other benign spots.

A standard CT of the abdomen is often taken at a single moment after contrast. The AAFP notes that this kind of single-phase study cannot fully characterise liver lesions, and that multiphase CT or MRI is preferred when a spot needs a closer look.

MRI shows how a lesion handles contrast over time, which helps tell cysts, haemangiomas and other lesions apart. The Hepatology Communications review describes contrast MRI with a liver-specific agent as the gold standard for characterising focal liver lesions. Contrast ultrasound is another option some centres use.

A further scan is not automatic. If a spot is tiny and you are at low risk, the team may decide that no more imaging is needed. If you are offered MRI, RadiologyInfo explains how body MRI works and advises telling staff about any devices or metal in your body and about your health problems and allergies.

Yes. The same spot can be handled differently depending on who it is found in. The Hepatology Communications review advises a higher level of caution in people with cirrhosis or a known cancer elsewhere in the body.

Cleveland Clinic lists cirrhosis and long-term hepatitis B or hepatitis C as factors that raise the risk of cancerous liver lesions. Cancer that started elsewhere, such as in the bowel or lung, can also spread to the liver. If any of these apply to you, your team may want a dedicated liver scan, a comparison with older scans, or a shorter follow-up interval.

If none apply, a tiny hypodense spot is usually far less concerning. Either way, the decision rests with the clinician who knows your full history and can see the images.

Bring the full radiology report, not just a portal summary, and any older scan reports. These questions can help structure the conversation:

• How big is the spot, and how many were seen?
• Does the report suggest a likely cause, such as a cyst or haemangioma, or is it truly uncharacterised?
• Was this a single-phase CT, and would a multiphase CT or MRI add anything in my case?
• Does my history, such as liver disease, hepatitis or a previous cancer, change how this is followed up?
• Can the spot be compared with any earlier scans I have had?
• If no further scan is planned, why is that considered safe for me, and what symptoms should make me get in touch sooner?
• Who will contact me with any follow-up plan, and by when?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar 'hypodense liver lesion' or 'too small to characterise' report talked it through with their teams can help you spot questions you had not thought of.

Other people's cases cannot tell you what your own spot is or whether you need another scan. We suggest using them to prepare for your appointment, then letting your own clinician interpret your images and history.